B RILEY FINANCIAL INC - RILY 5 1/4 08/31/28 (RILYZ)

US05580M8192

16.5  -0.14 (-0.84%)

Fundamental Rating

2

Overall RILYZ gets a fundamental rating of 2 out of 10. We evaluated RILYZ against 212 industry peers in the Capital Markets industry. RILYZ may be in some trouble as it scores bad on both profitability and health. RILYZ has a expensive valuation and it also scores bad on growth.



2

1. Profitability

1.1 Basic Checks

In the past year RILYZ has reported negative net income.
RILYZ had a positive operating cash flow in the past year.
In multiple years RILYZ reported negative net income over the last 5 years.
Of the past 5 years RILYZ 4 years had a positive operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of -3.49%, RILYZ is doing worse than 88.04% of the companies in the same industry.
Looking at the Return On Equity, with a value of -76.26%, RILYZ is doing worse than 92.34% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 1.95%, RILYZ is doing worse than 70.81% of the companies in the same industry.
Industry RankSector Rank
ROA -3.49%
ROE -76.26%
ROIC 1.95%
ROA(3y)0.98%
ROA(5y)2.8%
ROE(3y)-2.83%
ROE(5y)10.63%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

RILYZ has a Operating Margin of 8.23%. This is in the lower half of the industry: RILYZ underperforms 74.64% of its industry peers.
In the last couple of years the Operating Margin of RILYZ has declined.
RILYZ's Gross Margin of 67.58% is fine compared to the rest of the industry. RILYZ outperforms 69.86% of its industry peers.
RILYZ's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 8.23%
PM (TTM) N/A
GM 67.58%
OM growth 3Y-31.23%
OM growth 5Y-5.04%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.85%
GM growth 5Y-5.38%

0

2. Health

2.1 Basic Checks

The number of shares outstanding for RILYZ has been increased compared to 1 year ago.
Compared to 5 years ago, RILYZ has more shares outstanding
Compared to 1 year ago, RILYZ has a worse debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of -0.14, we must say that RILYZ is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -0.14, RILYZ is not doing good in the industry: 85.65% of the companies in the same industry are doing better.
The Debt to FCF ratio of RILYZ is 42.28, which is on the high side as it means it would take RILYZ, 42.28 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 42.28, RILYZ perfoms like the industry average, outperforming 40.67% of the companies in the same industry.
A Debt/Equity ratio of 18.53 is on the high side and indicates that RILYZ has dependencies on debt financing.
RILYZ has a Debt to Equity ratio of 18.53. This is amonst the worse of the industry: RILYZ underperforms 92.82% of its industry peers.
Industry RankSector Rank
Debt/Equity 18.53
Debt/FCF 42.28
Altman-Z -0.14
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 0.22 indicates that RILYZ may have some problems paying its short term obligations.
The Current ratio of RILYZ (0.22) is worse than 87.08% of its industry peers.
A Quick Ratio of 0.18 indicates that RILYZ may have some problems paying its short term obligations.
RILYZ has a worse Quick ratio (0.18) than 88.04% of its industry peers.
Industry RankSector Rank
Current Ratio 0.22
Quick Ratio 0.18

3

3. Growth

3.1 Past

The earnings per share for RILYZ have decreased strongly by -11.84% in the last year.
The Revenue has grown by 31.31% in the past year. This is a very strong growth!
The Revenue has been growing by 28.48% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-11.84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-434.63%
Revenue 1Y (TTM)31.31%
Revenue growth 3Y18.88%
Revenue growth 5Y28.48%
Sales Q2Q%-15.01%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for RILYZ. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, RILYZ is valued a bit cheaper than 77.03% of the companies in the same industry.
88.04% of the companies in the same industry are more expensive than RILYZ, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 4.99
EV/EBITDA 15.28

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

5

5. Dividend

5.1 Amount

RILYZ has a Yearly Dividend Yield of 8.63%, which is a nice return.
RILYZ's Dividend Yield is a higher than the industry average which is at 7.13.
Compared to an average S&P500 Dividend Yield of 2.37, RILYZ pays a better dividend.
Industry RankSector Rank
Dividend Yield 8.63%

5.2 History

On average, the dividend of RILYZ grows each year by 43.04%, which is quite nice.
RILYZ has been paying a dividend for less than 5 years, so it still needs to build a track record.
RILYZ has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)43.04%
Div Incr Years0
Div Non Decr Years3

5.3 Sustainability

RILYZ has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-67.91%
EPS Next 2YN/A
EPS Next 3YN/A

B RILEY FINANCIAL INC - RILY 5 1/4 08/31/28

NASDAQ:RILYZ (6/13/2024, 10:07:45 AM)

16.5

-0.14 (-0.84%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap499.95M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 8.63%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.49%
ROE -76.26%
ROCE
ROIC
ROICexc
ROICexgc
OM 8.23%
PM (TTM) N/A
GM 67.58%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.28
Health
Industry RankSector Rank
Debt/Equity 18.53
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.22
Quick Ratio 0.18
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-11.84%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)31.31%
Revenue growth 3Y18.88%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y